TP53 p.R337H is a conditional cancer-predisposing mutation: Further evidence from a homozygous patient

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Giacomazzi, Juliana ^a,b   Selistre, Simone ^a,b   Duarte, Juliana ^a   Ribeiro, Jorge Pinto ^a,b   Vieira, Paulo J C ^a   de Souza Macedo, Gabriel ^a,b   Rossi, Cristina ^a,b   Czepielewski, Mauro ^a,b   Netto, Cristina Brinkmann Oliveira ^a   Hainaut, Pierre ^c   Ashton Prolla, Patricia ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN P53; TP53 PROTEIN, HUMAN;

ADRENAL CORTEX CARCINOMA; ALLELE; ARTICLE; CASE REPORT; CHILD; EXERCISE TEST; FEMALE; FIBROBLAST; FOLLOW UP; FUNCTIONAL STATUS; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LYMPHOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; SCHOOL CHILD; TP53 GENE; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; CARCINOMA; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; HOMOZYGOTE; INFANT; LI-FRAUMENI SYNDROME; MALE; MIDDLE AGED; PATHOLOGY; PEDIGREE; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; YOUNG ADULT;

ADRENAL CORTEX NEOPLASMS; ADULT; AGED; CARCINOMA; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HOMOZYGOTE; HUMANS; INFANT; LI-FRAUMENI SYNDROME; MALE; MIDDLE AGED; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84875883755     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-187     Document Type: Article

References (36)

1. Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001, 20(34):4621-4628. 10.1038/sj.onc.1204621, 11498785.
2. Nichols NM, Matthews KS. p53 unfolding detected by CD but not by tryptophan fluorescence. Biochem Biophys Res Commun 2001, 288(1):111-115. 10.1006/bbrc.2001.5764, 11594760.
3. Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 2006, 130(1):73-79. 10.1053/j.gastro.2005.10.014, 16401470.
4. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250(4985):1233-1238. 10.1126/science.1978757, 1978757.
5. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990, 348(6303):747-749. 10.1038/348747a0, 2259385.
6. Latronico AC, Pinto EM, Domenice S, Fragoso MC, Martin RM, Zerbini MC, Lucon AM, Mendonca BB. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 2001, 86(10):4970-4973. 10.1210/jc.86.10.4970, 11600572.
7. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 2001, 98(16):9330-9335. 10.1073/pnas.161479898, 55420, 11481490.
8. DiGiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, Ribeiro RC, Zambetti G, Kriwacki RW. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 2002, 9(1):12-16. 10.1038/nsb730, 11753428.
9. Hainaut P. Tumor-specific mutations in p53: the acid test. Nat Med 2002, 8(1):21-23. 10.1038/nm0102-21, 11786899.
10. Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett 2007, 245(1-2):96-102.
11. Assumpção JG, Seidinger AL, Mastellaro MJ, Ribeiro RC, Zambetti GP, Ganti R, Srivastava K, Shurtleff S, Pei D, Zeferino LC. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 2008, 8:357. 10.1186/1471-2407-8-357, 2631588, 19046423.
12. Garritano S, Gemignani F, Palmero EI, Olivier M, Martel-Planche G, Le Calvez-Kelm F, Brugiéres L, Vargas FR, Brentani RR, Ashton-Prolla P. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Hum Mutat 2010, 31(2):143-150. 10.1002/humu.21151, 19877175.
13. Pinto EM, Billerbeck AE, Villares MC, Domenice S, Mendonça BB, Latronico AC. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq Bras Endocrinol Metabol 2004, 48(5):647-650.
14. Palmero EI, Schüler-Faccini L, Caleffi M, Achatz MI, Olivier M, Martel-Planche G, Marcel V, Aguiar E, Giacomazzi J, Ewald IP. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett 2008, 261(1):21-25. 10.1016/j.canlet.2007.10.044, 18248785.
15. Piovezan GC. Prevalência do alelo R337H no Estado do Paraná 2006, Universidade Federal do Paraná: Masters degree dissertation, 2663548, 19284622.
16. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 2006, 312(5780):1650-1653. 10.1126/science.1126863, 16728594.
17. Park JY, Wang PY, Matsumoto T, Sung HJ, Ma W, Choi JW, Anderson SA, Leary SC, Balaban RS, Kang JG. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res 2009, 105(7):705-712. 711 p following 712, 10.1161/CIRCRESAHA.109.205310, 2761626, 19696408.
18. Wang PY, Zhuang J, Hwang PM. p53: exercise capacity and metabolism. Curr Opin Oncol 2012, 24(1):76-82. 10.1097/CCO.0b013e32834de1d8, 22123233.
19. National Comprehensive Cancer Network (NCCN) Guidelines guidelines 2012, Available from URL: (http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#genetics_screening), National Comprehensive Cancer Network (NCCN) Guidelines guidelines.
20. American Thoracic Society and American College of Chest Physicians 2003, Available from URL: http://www.thoracic.org/statements/resources/pfet/cardioexercise.pdf, American Thoracic Society and American College of Chest Physicians.
21. Chiappa GR, Ribeiro JP, Alves CN, Vieira PJ, Dubas J, Queiroga F, Batista LD, Silva AC, Neder JA. Inspiratory resistive loading after all-out exercise improves subsequent performance. Eur J Appl Physiol 2009, 106(2):297-303. 10.1007/s00421-009-1022-9, 19266213.
22. Ten Harkel AD, Takken T, Van Osch-Gevers M, Helbing WA. Normal values for cardiopulmonary exercise testing in children. Eur J Cardiovasc Prev Rehabil 2011, 18(1):48-54.
23. Welsman J, Bywater K, Farr C, Welford D, Armstrong N. Reliability of peak VO(2) and maximal cardiac output assessed using thoracic bioimpedance in children. Eur J Appl Physiol 2005, 94(3):228-230. 10.1007/s00421-004-1300-5, 15827735.
24. International Agency for Research on Cancer (IARC) TP53 database 2012, Available from URL: http://p53.iarc.fr/Download/TP53_DirectSequencing_IARC.pdf, International Agency for Research on Cancer (IARC) TP53 database.
25. Laffan EE, O'Connor R, Ryan SP, Donoghue VB. Whole-body magnetic resonance imaging: a useful additional sequence in paediatric imaging. Pediatr Radiol 2004, 34(6):472-480. 10.1007/s00247-004-1184-x, 15107961.
26. Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, Novokmet A, Finlay J, Malkin D. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 2011, 12(6):559-567. 10.1016/S1470-2045(11)70119-X, 21601526.
27. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004, 22(4):275-282.
28. Ording Müller LS, Avenarius D, Olsen OE. High signal in bone marrow at diffusion-weighted imaging with body background suppression (DWIBS) in healthy children. Pediatr Radiol 2011, 41(2):221-226. 10.1007/s00247-010-1774-8, 20652234.
29. Lalloo F, Varley J, Ellis D, Moran A, O'Dair L, Pharoah P, Evans DG, Group EOBCS. Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 2003, 361(9363):1101-1102. 10.1016/S0140-6736(03)12856-5, 12672316.
30. Latronico AC, Pinto EM, Domenice S, Fragoso MC, Martin RM, Zerbini MC, Lucon AM, Mendonca BB. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 2001, 86(10):4970-4973. 10.1210/jc.86.10.4970, 11600572.
31. Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 2008, 26(4):542-548. 10.1200/JCO.2007.12.5922, 18172190.
32. Adank MA, Jonker MA, Kluijt I, van Mil SE, Oldenburg RA, Mooi WJ, Hogervorst FB, van den Ouweland AM, Gille JJ, Schmidt MK. CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women. J Med Genet 2011, 48(12):860-863. 10.1136/jmedgenet-2011-100380, 22058428.
33. Krüger S, Kinzel M, Walldorf C, Gottschling S, Bier A, Tinschert S, von Stackelberg A, Henn W, Gorgens H, Boue S. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet 2008, 16(1):62-72. 10.1038/sj.ejhg.5201923, 17851451.
34. Toledano H, Goldberg Y, Kedar-Barnes I, Baris H, Porat RM, Shochat C, Bercovich D, Pikarsky E, Lerer I, Yaniv I. Homozygosity of MSH2 c.1906G-C germline mutation is associated with childhood colon cancer, astrocytoma and signs of Neurofibromatosis type I. Fam Cancer 2009, 8(3):187-194. 10.1007/s10689-008-9227-3, 19101824.
35. Hagberg JM, Coyle EF, Carroll JE, Miller JM, Martin WH, Brooke MH. Exercise hyperventilation in patients with McArdle's disease. J Appl Physiol 1982, 52(4):991-994.
36. Ivy JL, Withers RT, Van Handel PJ, Elger DH, Costill DL. Muscle respiratory capacity and fiber type as determinants of the lactate threshold. J Appl Physiol 1980, 48(3):523-527.